Moon; Jai-Hee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moon; Jai-Hee.The latest application filed is for "thienopyridine derivatives and pharmaceutical composition comprising same".

Company Profile

4.10.16

Moon; Jai-Hee - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thienopyridine derivatives and pharmaceutical composition comprising same Grant 11,447,500 - Lee , et al. September 20, 2	2022-09-20
Thienopyridine Derivatives And Pharmaceutical Composition Comprising Same App 20220288043 - LEE; Hyunho ; et al.	2022-09-15
Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET) Grant 11,186,873 - Jin , et al. November 30, 2	2021-11-30
Thienopyridine Derivatives And Pharmaceutical Composition Comprising Same App 20210317133 - LEE; Hyunho ; et al.	2021-10-14
Novel Biomarker For Predicting Sensitivity To Egfr-targeting Agent, And Use Thereof App 20210292849 - Kim; Tae Won ; et al.	2021-09-23
Novel Biomarker For Predicting Sensitiviy To Egfr-targeting Agent, And Use Thereof App 20210292848 - Kim; Tae Won ; et al.	2021-09-23
Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof Grant 11,008,622 - Kim , et al. May 18, 2	2021-05-18
Method For Determining Sensitivity To Simultaneous Inhibitor Against Parp And Tankyrase App 20200354794 - Jin; Dong Hoon ; et al.	2020-11-12
Method for determining sensitivity to simultaneous inhibitor against PARP and Tankyrase Grant 10,683,553 - Jin , et al.	2020-06-16
Novel Biomarker For Predicting Sensitivity To Egfr-targeting Agent, And Use Thereof App 20190127802 - Kim; Tae Won ; et al.	2019-05-02
Method For Determining Sensitivity To Simultaneous Inhibitor Against Parp And Tankyrase App 20180327851 - Jin; Dong Hoon ; et al.	2018-11-15
Biomarker For Predicting The Sensitivity To A Protein Kinase Inhibitor And A Use Thereof App 20180180616 - KIM; Tae Won ; et al.	2018-06-28
Novel Biomarker For Predicting Sensitivity To Met Inhibitor, And Use Thereof App 20170327894 - Jin; Dong Hoon ; et al.	2017-11-16
Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient Grant 9,752,151 - Kim , et al. September 5, 2	2017-09-05
Composition for Treatment or Metastasis Suppression of Cancers Which Includes P34 Expression Inhibitor or Activity Inhibitor as Active Ingredient App 20160040168 - Kim; Tae Won ; et al.	2016-02-11
Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Oct4 in combination with Bmi1 or its upstream regulator, and method for generating induced pluripotent stem cells using the same Grant 8,772,031 - You , et al. July 8, 2	2014-07-08
Composition for improving skin conditions using fetal mesenchymal stem cells from amniotic fluid Grant 8,586,540 - You , et al. November 19, 2	2013-11-19
COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Oct4 IN COMBINATION WITH Bmi1 OR ITS UPSTREAM REGULATOR, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAME App 20130280808 - You; Seungkwon ; et al.	2013-10-24
Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Bmi1 and low molecular weight substance, and method for generating induced pluripotent stem cells using the same Grant 8,518,700 - You , et al. August 27, 2	2013-08-27
Composition for Improving Skin Conditions Using Fetal Mesenchymal Stem Cells from Amniotic Fluid App 20120141399 - You; Seungkwon ; et al.	2012-06-07
COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Bmi1 AND LOW MOLECULAR WEIGHT SUBSTANCE, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAME App 20110275157 - YOU; Seungkwon ; et al.	2011-11-10
COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Oct4 IN COMBINATION WITH Bmi1 OR ITS UPSTREAM REGULATOR, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAME App 20110159592 - YOU; Seungkwon ; et al.	2011-06-30
De-differentiation Of Astrocytes Into Neural Stem Cell Using Nanog App 20090246870 - You; Seungkwon ; et al.	2009-10-01
DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh App 20090227023 - You; Seungkwon ; et al.	2009-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.